capecitabine 150mg

Generic: capecitabine

Labeler: armas pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name capecitabine 150mg
Generic Name capecitabine
Labeler armas pharmaceuticals inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

capecitabine 150 mg/1

Manufacturer
Armas Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 72485-204
Product ID 72485-204_680dac89-d210-4eb8-a955-bf40e652c546
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207456
Listing Expiration 2026-12-31
Marketing Start 2019-03-01

Pharmacologic Class

Established (EPC)
nucleoside metabolic inhibitor [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72485204
Hyphenated Format 72485-204

Supplemental Identifiers

RxCUI
200327
UNII
6804DJ8Z9U
NUI
N0000000233 N0000175595

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name capecitabine 150mg (source: ndc)
Generic Name capecitabine (source: ndc)
Application Number ANDA207456 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (72485-204-60) / 60 TABLET, FILM COATED in 1 BOTTLE
source: ndc

Packages (1)

72485-204-60 1 BOTTLE in 1 CARTON (72485-204-60) / 60 TABLET, FILM COATED in 1 BOTTLE

Ingredients (1)

capecitabine (150 mg/1)

Linked Drug Pages (1)

Capecitabine 150mg ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "680dac89-d210-4eb8-a955-bf40e652c546", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["6804DJ8Z9U"], "rxcui": ["200327"], "spl_set_id": ["7f555b6b-60db-45e2-a61e-537e57f43fdc"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (72485-204-60)  / 60 TABLET, FILM COATED in 1 BOTTLE", "package_ndc": "72485-204-60", "marketing_start_date": "20190301"}], "brand_name": "Capecitabine 150mg", "product_id": "72485-204_680dac89-d210-4eb8-a955-bf40e652c546", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "72485-204", "generic_name": "Capecitabine", "labeler_name": "Armas Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Capecitabine 150mg", "active_ingredients": [{"name": "CAPECITABINE", "strength": "150 mg/1"}], "application_number": "ANDA207456", "marketing_category": "ANDA", "marketing_start_date": "20190301", "listing_expiration_date": "20261231"}